Simona Stolnicu
Overview
Explore the profile of Simona Stolnicu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
146
Citations
646
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Zannoni G, Santoro A, Addante F, Cianfrini F, Stolnicu S
Pathol Res Pract
. 2024 Jan;
254:155062.
PMID: 38199133
HPV-independent in situ adenocarcinomas have been only recently added to the WHO 2020 classification. To date, little information has been published about HPVindependent precursor lesions. In particular, regardiong the extremely...
12.
Stolnicu S, Praiss A, Allison D, Tessier-Cloutier B, Flynn J, Iasonos A, et al.
Int J Gynecol Pathol
. 2023 Dec;
43(3):203-214.
PMID: 38085957
We compared grading systems and examined associations with tumor stroma and survival in patients with cervical squamous cell carcinoma. Available tumor slides were collected from 10 international institutions. Broders tumor...
13.
Stolnicu S, Patrichi A, Rozsnyai F, Soslow R
Pol J Pathol
. 2023 Nov;
74(3):216-218.
PMID: 37955541
We present the case of a 71-year-old patient, with vaginal bleeding, dyspnea, headache, loss of appetite and weakness. Clinical examination revealed a pediculated vaginal mass of 25 mm diameter, of ...
14.
Stolnicu S, Allison D, Praiss A, Tessier-Cloutier B, Momeni Boroujeni A, Flynn J, et al.
Am J Surg Pathol
. 2023 Sep;
47(12):1376-1389.
PMID: 37702216
We aimed to determine the frequency of human papillomavirus-independent (HPVI) cervical squamous cell carcinoma (SCC) and to describe clinicopathologic characteristics. Among 670 patients with surgically treated SCCs in an established...
15.
Stolnicu S, Allison D, Patrichi A, Flynn J, Iasonos A, Soslow R
Adv Anat Pathol
. 2023 Aug;
31(1):1-14.
PMID: 37638549
Cervical cancer is the fourth most common cancer among women globally. Historically, human papillomavirus (HPV) infection was considered necessary for the development of both precursor and invasive epithelial tumors of...
16.
Praiss A, Allison D, Tessier-Cloutier B, Flynn J, Iasonos A, Hoang L, et al.
Gynecol Oncol
. 2023 Aug;
176:147-154.
PMID: 37541128
Objective: We evaluated clinicopathologic parameters of patients with cervical squamous cell carcinoma (SCC) who were treated with initial surgical management and assessed their relation to survival outcomes. Specifically, we evaluated...
17.
Dundr P, Hajkova N, Kendall Bartu M, Cibula D, Drozenova J, Fabian P, et al.
Pathology
. 2023 Jul;
55(6):785-791.
PMID: 37500307
In gynecological neoplasms, immunohistochemical (IHC) expression of p53 is generally an accurate predictor of TP53 mutation status if correctly interpreted by the pathologist. However, the literature concerning cut-offs, frequency and...
18.
Kendall Bartu M, Nemejcova K, Michalkova R, Bui Q, Drozenova J, Fabian P, et al.
Int J Gynecol Pathol
. 2023 Jul;
43(2):123-133.
PMID: 37406366
Expression of neuroendocrine (NE) markers in primary ovarian non-NE epithelial tumors has rarely been evaluated. The aim of our study was to evaluate the expression of the most widely used...
19.
Hajkova N, Kendall Bartu M, Cibula D, Drozenova J, Fabian P, Fadare O, et al.
Transl Res
. 2023 May;
260:61-68.
PMID: 37244485
Testing of microsatellite instability is not only used as a triage for possible Lynch syndrome, but also to predict immunotherapy treatment response. The aim of this study was to assess...
20.
Dundr P, Bartu M, Bosse T, Bui Q, Cibula D, Drozenova J, et al.
Mod Pathol
. 2023 Feb;
36(1):100040.
PMID: 36788074
Primary ovarian mucinous tumors represent a heterogeneous group of neoplasms, and their diagnosis may be challenging. We analyzed 124 primary ovarian mucinous tumors originally diagnosed as mucinous borderline tumors (MBTs)...